Company Overview and News

11
Idera Pharmaceuticals Announces Appointment of Howard Pien to its Board of Directors

2018-09-18 globenewswire
EXTON, Pa., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, tilsotolimod, for the treatment of cancer, today announced that Howard Pien joined its Board of Directors, effective September 18, 2018.
ABT SAGE INVVY IDRAW JUNO IDRA VNDA IZQVF ABT

126
Your Daily Scoop: Recro Proceeds, MannKind Zooms, Aduro's Publication

2018-09-07 seekingalpha - 3
Discussion: On September 4, Recro Pharma (REPH) reported positive outcome of its meeting with the FDA regarding its NDA for IV meloxicam that was rejected in last May. Based on the discussion with the FDA, the company now plans to submit a revised NDA by the end of this month. Suggestions offered by the FDA now guides the company to include revised labelling language and further information on extractable and leachable items.
DOVA MNKD SYBX TSRO REDIF AST OPK RDHL PBYI ZGNX SNGX DVAX ADRO ALXN BIIB AGLE EIGR HZNP EYEG HSDT CHEK EYEGW SNY BCRX SAGE REPH JNJ UTHR APLS

10
Ligand (LGND) Up 4.6% Since Last Earnings Report: Can It Continue?

2018-09-05 zacks
It has been about a month since the last earnings report for Ligand Pharmaceuticals (LGND - Free Report) . Shares have added about 4.6% in that time frame, outperforming the S&P 500.
SAGE LGNZZ ALDX SPPI LGND LGNYZ LGNXZ LGNDZ

17
Ligand: My Favorite Biotech Stock

2018-08-20 seekingalpha - 6
There are numerous small biotech stocks that will no longer be around several years from now.
SAGE CASI VKTXW LGNZZ SPPI LGND LGNYZ LGNXZ VKTX LGNDZ

 
Sage Therapeutics 2018 Q2 - Results - Earnings Call Slides

2018-08-08 seekingalpha
The following slide deck was published by Sage Therapeutics in conjunction with their 2018 Q2 earnings call.
SAGE

 
SAGE Therapeutics, Inc. (SAGE) CEO Jeffrey Jonas on Q2 2018 Results - Earnings Call Transcript

2018-08-07 seekingalpha
Good morning, and welcome to Sage Therapeutics' Second Quarter 2018 Financial Results Conference Call. [Operator Instructions]. This call is being webcast live on the Investors & Media section of Sage's website at sagerx.com. This call is a property of Sage Therapeutics and recordings, reproductions or transmission of this call without the express written consent of Sage Therapeutics is strictly prohibited.
SAGE

12
Ligand (LGND) Beats on Q2 Earnings & Revenues, Raises View

2018-08-07 zacks - 1
Ligand Pharmaceuticals Incorporated (LGND - Free Report) reported second-quarter 2018 adjusted earnings of $2.59 per share, significantly up from the year-ago figure of 67 cents. The bottom line also beat the Zacks Consensus Estimate of 93 cents.
SAGE AMGN SPPI LGNZZ ALDX LGND LGNYZ NVS LGNXZ LGNDZ WXXWY

 
SAGE / Sage Therapeutics, Inc. 10-Q (Quarterly Report)

2018-08-07 sec.gov
sage-10q_20180630.htm UNITED STATES
SAGE

 
SAGE / Sage Therapeutics, Inc. 8-K (Current Report)

2018-08-07 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SAGE

8
Ligand's (LGND) CEO John Higgins on Q2 2018 Results - Earnings Call Transcript

2018-08-07 seekingalpha - 1
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q2 2018 Results Earnings Conference Call August 6, 2018 4:30 PM ET
SAGE VKTXW LGNZZ LGND LGNYZ LGNXZ VKTX LGNDZ MEIP WXXWY APRI

63
10 Strong Buy Stocks From the Best Analysts on Wall Street

2018-07-26 investorplace - 2
Now more than ever, it makes sense to listen to analysts with a proven track record of success. Anyone can claim to be a market expert. Anyone can have an opinion. But that opinion becomes a lot more meaningful when the figures show that this person tends to be right.
LOW DB MCHP SAGE WFM BABA AMZN IMMU MU GPOR NTR MS UNH

 
Two Tech Companies Develop Platforms to Help In the Fight Against Mental Illness

2018-07-23 biospace
Over the years there have been questions surrounding the efficacy of some medications used to treat mental health issues. Last year a Harvard professor argued on CBS’ 60 Minutes that there was little difference between a psychiatric drug and a placebo.
SAGE

 
ADHD Check-Up: Which Future Medications Have The Greatest Potential?

2018-07-18 seekingalpha
The ADHD market is crowded, but new compounds could still get a piece of a large market.
SAGE SMDPY KMPH

1
Evolving Systems said it does not expect any change to outlook due to firing of CEO

2018-07-18 marketwatch
Evolving Systems said it does not expect any change to outlook due to firing of CEO
SAGE PFPT EVOL NAII AERI

116
China Blinked - Cramer's Mad Money (7/12/18)

2018-07-13 seekingalpha - 1
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, July 12.
APC FB CHDN MA NFLX AXP GOOG VICI SAGE V AMZN JNJ AAPL TSLA KSS PENN AEUA BYD

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to SAGE / Sage Therapeutics, Inc. on message board site Silicon Investor.

Sage Theraputic RG (SAGE) Sage Theraputic RG (SAGE) Sage Theraputic RG (SAGE) Please Post a Message Please Post a Message Please Post a Message
Bernie Sanders Comedy Message Board 2016 Bernie Sanders Comedy Message Board 2016 Bernie Sanders Comedy Message Board 2016 Islam, The Message Islam, The Message Islam, The Message
Aerodynamic technology and clever usage ? Aerodynamic technology and clever usage ? Aerodynamic technology and clever usage ? Bobu0027s blog/diary/message-board/ramblings Bobu0027s blog/diary/message-board/ramblings Bobu0027s blog/diary/message-board/ramblings
Viisage Technology (VISG) Viisage Technology (VISG) Viisage Technology (VISG) OSGE - Osage Energy Corp. OSGE - Osage Energy Corp. OSGE - Osage Energy Corp.
Post messages here which regulators should read Post messages here which regulators should read Post messages here which regulators should read Send A Message To France Send A Message To France Send A Message To France
CUSIP: 78667J108